Prudential Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4K | Sell |
21,791
-51,500
| -70% | -$57.7K | ﹤0.01% | 2391 |
|
|
2025
Q1 | $57.9K | Sell |
73,291
-248,110
| -77% | -$196K | ﹤0.01% | 2182 |
|
|
2024
Q4 | $530K | Sell |
321,401
-35,200
| -10% | -$58.1K | ﹤0.01% | 1809 |
|
|
2024
Q3 | $1.25M | Buy |
356,601
+500
| +0.1% | +$1.75K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $1.17M | Sell |
356,101
-27,100
| -7% | -$88.9K | ﹤0.01% | 1738 |
|
|
2024
Q1 | $2.81M | Sell |
383,201
-176,810
| -32% | -$1.3M | ﹤0.01% | 1246 |
|
|
2023
Q4 | $2.09M | Buy |
560,011
+365,100
| +187% | +$1.37M | ﹤0.01% | 1406 |
|
|
2023
Q3 | $413K | Buy |
194,911
+128,600
| +194% | +$273K | ﹤0.01% | 2141 |
|
|
2023
Q2 | $316K | Sell |
66,311
-93,600
| -59% | -$446K | ﹤0.01% | 2282 |
|
|
2023
Q1 | $911K | Buy |
+159,911
| New | +$911K | ﹤0.01% | 1795 |
|
|
2022
Q2 | – | Sell |
-6,766
| Closed | -$262K | – | 2695 |
|
|
2022
Q1 | $262K | Sell |
6,766
-62
| -0.9% | -$2.4K | ﹤0.01% | 2448 |
|
|
2021
Q4 | $408K | Sell |
6,828
-66,188
| -91% | -$3.95M | ﹤0.01% | 2281 |
|
|
2021
Q3 | $4.42M | Sell |
73,016
-1,514
| -2% | -$91.6K | 0.01% | 1046 |
|
|
2021
Q2 | $6.47M | Buy |
74,530
+9,555
| +15% | +$829K | 0.01% | 927 |
|
|
2021
Q1 | $5.36M | Sell |
64,975
-4,053
| -6% | -$334K | 0.01% | 991 |
|
|
2020
Q4 | $6.28M | Buy |
69,028
+14,623
| +27% | +$1.33M | 0.01% | 917 |
|
|
2020
Q3 | $2.18M | Sell |
54,405
-2,660
| -5% | -$106K | ﹤0.01% | 1293 |
|
|
2020
Q2 | $1.96M | Sell |
57,065
-19,794
| -26% | -$679K | ﹤0.01% | 1349 |
|
|
2020
Q1 | $1.71M | Buy |
76,859
+220
| +0.3% | +$4.89K | ﹤0.01% | 1450 |
|
|
2019
Q4 | $1.5M | Buy |
+76,639
| New | +$1.5M | ﹤0.01% | 1715 |
|